Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression.
Shiota M, Sekino Y, Tsukahara S, Abe T, Kinoshita F, Imada K, Ueda S, Ushijima M, Nagakawa S, Matsumoto T, Kashiwagi E, Takeuchi A, Inokuchi J, Uchiumi T, Oda Y, Eto M. Shiota M, et al. Among authors: nagakawa s. Cancer Sci. 2021 Jan;112(1):323-330. doi: 10.1111/cas.14695. Epub 2020 Nov 24. Cancer Sci. 2021. PMID: 33064355 Free PMC article.
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.
Nagakawa S, Shiota M, Fujimoto N, Yamamoto Y, Blas L, Tsukahara S, Matsumoto T, Kashiwagi E, Takeuchi A, Inokuchi J, Uchiumi T, Matsuyama H, Eto M. Nagakawa S, et al. Urol Oncol. 2021 Oct;39(10):733.e17-733.e24. doi: 10.1016/j.urolonc.2021.05.034. Epub 2021 Jun 29. Urol Oncol. 2021. PMID: 34215507
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
Tsukahara S, Shiota M, Takamatsu D, Nagakawa S, Matsumoto T, Kiyokoba R, Yagi M, Setoyama D, Noda N, Matsumoto S, Hayashi T, Contreras-Sanz A, Black PC, Inokuchi J, Kohashi K, Oda Y, Uchiumi T, Eto M, Kang D. Tsukahara S, et al. Among authors: nagakawa s. Sci Rep. 2022 May 20;12(1):8535. doi: 10.1038/s41598-022-12528-3. Sci Rep. 2022. PMID: 35595780 Free PMC article.
Androgen receptor mutations for precision medicine in prostate cancer.
Shiota M, Akamatsu S, Tsukahara S, Nagakawa S, Matsumoto T, Eto M. Shiota M, et al. Among authors: nagakawa s. Endocr Relat Cancer. 2022 Aug 17;29(10):R143-R155. doi: 10.1530/ERC-22-0140. Print 2022 Oct 1. Endocr Relat Cancer. 2022. PMID: 35900853 Review.
24 results